APOL5

gene
On this page

Also known as APOLV

Summary

APOL5 (apolipoprotein L5, HGNC:14869) is a protein-coding gene on chromosome 22q12.3, encoding Apolipoprotein L5 (Q9BWW9). May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.

This gene is a member of the apolipoprotein L gene family. The encoded protein is found in the cytoplasm, where it may affect the movement of lipids or allow the binding of lipids to organelles.

Source: NCBI Gene 80831 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 81 total
  • MANE Select transcript: NM_030642

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:14869
Approved symbolAPOL5
Nameapolipoprotein L5
Location22q12.3
Locus typegene with protein product
StatusApproved
AliasesAPOLV
Ensembl geneENSG00000128313
Ensembl biotypeprotein_coding
OMIM607255
Entrez80831

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000249044

RefSeq mRNA: 1 — MANE Select: NM_030642 NM_030642

CCDS: CCDS13920

Canonical transcript exons

ENST00000249044 — 5 exons

ExonStartEnd
ENSE000008800213572621135727194
ENSE000008800223572872335728904
ENSE000009112443571787235717926
ENSE000009360343572935435729483
ENSE000012757373572056835720654

Expression profiles

Bgee: expression breadth broad, 36 present calls, max score 84.33.

Top tissues by expression

99 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.33silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099179.37silver quality
hindlimb stylopod muscleUBERON:000425259.00gold quality
skeletal muscle tissueUBERON:000113457.41gold quality
muscle of legUBERON:000138353.23gold quality
gastrocnemiusUBERON:000138850.61gold quality
muscle tissueUBERON:000238550.05gold quality
right lobe of liverUBERON:000111447.75gold quality
lower esophagus mucosaUBERON:003583446.69silver quality
liverUBERON:000210746.66gold quality
gall bladderUBERON:000211044.48gold quality
apex of heartUBERON:000209842.11silver quality
prefrontal cortexUBERON:000045140.60gold quality
heart left ventricleUBERON:000208439.53gold quality
left testisUBERON:000453339.30gold quality
testisUBERON:000047338.78gold quality
subcutaneous adipose tissueUBERON:000219038.61silver quality
primary visual cortexUBERON:000243638.45silver quality
anterior cingulate cortexUBERON:000983537.98silver quality
thoracic mammary glandUBERON:000520037.75gold quality
frontal cortexUBERON:000187037.67gold quality
ganglionic eminenceUBERON:000402337.36gold quality
colonic epitheliumUBERON:000039737.20gold quality
right testisUBERON:000453437.14gold quality
heartUBERON:000094837.01gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
dorsolateral prefrontal cortexUBERON:000983436.24silver quality
bone marrow cellCL:000209236.16gold quality
mucosa of stomachUBERON:000119936.03silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.66

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

8 targeting APOL5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-1212199.9966.64255
HSA-MIR-4715-3P99.9866.03670
HSA-MIR-361-3P99.1966.451381
HSA-MIR-431798.4967.09987
HSA-MIR-1912-5P97.9467.98832
HSA-MIR-3152-5P96.9866.88819
HSA-MIR-1212896.6766.981471

Literature-anchored findings (GeneRIF, showing 1)

  • APOL5 has been found only in humans (PMID:11374903)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioapolENSDARG00000073718
caenorhabditis_elegansWBGENE00017219
caenorhabditis_elegansWBGENE00017220

Paralogs (6): APOL4 (ENSG00000100336), APOL1 (ENSG00000100342), APOL3 (ENSG00000128284), APOL2 (ENSG00000128335), APOLD1 (ENSG00000178878), APOL6 (ENSG00000221963)

Protein

Protein identifiers

Apolipoprotein L5Q9BWW9 (reviewed: Q9BWW9)

Alternative names: Apolipoprotein L-V

All UniProt accessions (1): Q9BWW9

UniProt curated annotations — full annotation on UniProt →

Function. May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.

Subcellular location. Cytoplasm.

Tissue specificity. Low level of expression; detected in uterus, testis, skeletal muscle and stomach.

Similarity. Belongs to the apolipoprotein L family.

RefSeq proteins (1): NP_085145* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR008405ApoLFamily

Pfam: PF05461

UniProt features (8 total): sequence variant 4, compositionally biased region 2, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BWW9-F141.660.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 22 (showing top): GOBP_LIPOPROTEIN_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_LOCALIZATION, GOMF_PROTEIN_LIPID_COMPLEX_BINDING, GOMF_LIPID_BINDING, GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING, GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING, ZNF22_TARGET_GENES, MIR4317, chr22q12, DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS, DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS, NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP, GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN

GO Biological Process (3): lipid metabolic process (GO:0006629), lipid transport (GO:0006869), lipoprotein metabolic process (GO:0042157)

GO Molecular Function (2): high-density lipoprotein particle binding (GO:0008035), lipid binding (GO:0008289)

GO Cellular Component (2): extracellular region (GO:0005576), cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
primary metabolic process1
transport1
lipid localization1
protein metabolic process1
lipoprotein particle binding1
binding1
intracellular anatomical structure1

Protein interactions and networks

STRING

304 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
APOL5COMTP21964649
APOL5HPRP00739478
APOL5CIMIP2CA6NJV1447
APOL5APOC4P55056419
APOL5PI4KBP78405415
APOL5APOOQ9BUR5399
APOL5NT5DC4Q86YG4393
APOL5APOFQ13790377
APOL5NAPRTQ6XQN6372
APOL5ZNF441Q8N8Z8371
APOL5APOL1O14791363
APOL5YKT6O15498362
APOL5APOL4Q9BPW4352
APOL5APOLD1Q96LR9351
APOL5APOMO95445336

IntAct

10 interactions, top by confidence:

ABTypeScore
ABL1APOL5psi-mi:“MI:0915”(physical association)0.400
APOL5CRKpsi-mi:“MI:0915”(physical association)0.400
SRCAPOL5psi-mi:“MI:0915”(physical association)0.400
FYNAPOL5psi-mi:“MI:0915”(physical association)0.400
GRB2APOL5psi-mi:“MI:0915”(physical association)0.400
APOL5NCK1psi-mi:“MI:0915”(physical association)0.400
APOL5PIK3R1psi-mi:“MI:0915”(physical association)0.400
APOL5CLTCL1psi-mi:“MI:0915”(physical association)0.400
KLHL22TRAV18psi-mi:“MI:0914”(association)0.350

BioGRID (2): CLTCL1 (Affinity Capture-MS), APOL5 (Affinity Capture-MS)

ESM2 similar proteins: A0A140LIF8, A0JN92, A7UHZ5, O08602, O08603, O08604, O14791, O15482, O77812, O95236, P01574, P01575, P01576, P01577, P01578, P05012, P59045, P70499, Q2KHK6, Q3B7D9, Q3TR54, Q3UQS2, Q56XQ0, Q5NCI0, Q5PPP4, Q5RFJ8, Q60766, Q6AYC2, Q6XZW6, Q6ZSC3, Q7TPX8, Q80ZF2, Q810Y8, Q86WN2, Q8BVM9, Q8CB12, Q8CCN1, Q8TCY9, Q99388, Q99J64

Diamond homologs: O14791, O95236, Q9BPW4, Q9BQE5, Q9BWW8, Q9BWW9, Q96LR9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

81 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance69
Likely benign6
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

685 predictions. Top by Δscore:

VariantEffectΔscore
22:35720460:A:AGacceptor_gain0.9900
22:35717924:CTGG:Cdonor_loss0.9800
22:35717927:G:GGdonor_gain0.9800
22:35726270:A:AGacceptor_gain0.9800
22:35726271:G:GGacceptor_gain0.9800
22:35720461:A:Gacceptor_gain0.9700
22:35726271:GTGAT:Gacceptor_gain0.9700
22:35717923:CCTG:Cdonor_gain0.9500
22:35717925:TG:Tdonor_gain0.9500
22:35717926:GG:Gdonor_gain0.9500
22:35720581:TTGTA:Tdonor_gain0.9500
22:35726397:A:Gacceptor_gain0.9500
22:35728753:T:TAacceptor_gain0.9500
22:35717924:CTG:Cdonor_gain0.9400
22:35726394:A:AGacceptor_gain0.9400
22:35720468:A:AGacceptor_gain0.9300
22:35726271:GT:Gacceptor_gain0.9300
22:35729352:A:AGacceptor_gain0.9300
22:35729353:G:GGacceptor_gain0.9300
22:35726395:C:Gacceptor_gain0.9100
22:35729352:AGTT:Aacceptor_gain0.9100
22:35729353:GTTG:Gacceptor_gain0.9100
22:35726393:CACA:Cacceptor_gain0.8800
22:35726394:ACAA:Aacceptor_gain0.8800
22:35726270:AGT:Aacceptor_gain0.8700
22:35726271:GTG:Gacceptor_gain0.8700
22:35726307:A:Cacceptor_gain0.8700
22:35727191:GAAG:Gdonor_gain0.8500
22:35720582:T:TAdonor_gain0.8200
22:35728721:AG:Aacceptor_gain0.8200

AlphaMissense

2813 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
22:35726384:T:CF106L0.877
22:35726386:T:AF106L0.877
22:35726386:T:GF106L0.877
22:35726831:T:CF255L0.869
22:35726833:C:AF255L0.869
22:35726833:C:GF255L0.869
22:35726564:A:CS166R0.846
22:35726566:T:AS166R0.846
22:35726566:T:GS166R0.846
22:35726372:T:CF102L0.824
22:35726374:T:AF102L0.824
22:35726374:T:GF102L0.824
22:35726906:T:CF280L0.815
22:35726908:T:AF280L0.815
22:35726908:T:GF280L0.815
22:35726876:T:CF270L0.802
22:35726878:C:AF270L0.802
22:35726878:C:GF270L0.802
22:35726852:T:CF262L0.796
22:35726854:T:AF262L0.796
22:35726854:T:GF262L0.796
22:35726427:T:CL120P0.777
22:35726438:G:CA124P0.769
22:35726538:C:AA157D0.759
22:35726508:T:AV147D0.750
22:35726606:G:CA180P0.748
22:35726469:T:CL134P0.736
22:35727058:A:CR330S0.733
22:35727058:A:TR330S0.733
22:35726399:T:CF111L0.730

dbSNP variants (sampled 300 via entrez): RS1000023230 (22:35727774 A>G), RS1000085795 (22:35721453 G>C), RS1000138979 (22:35707758 A>G), RS1000235641 (22:35712065 G>T), RS1000301863 (22:35716966 A>G), RS1000319154 (22:35722957 T>C), RS1000387332 (22:35715593 G>A), RS1000435312 (22:35722670 G>C), RS1000459653 (22:35727352 G>C), RS1000652555 (22:35716733 A>C,T), RS1000731148 (22:35706620 C>T), RS1000790405 (22:35712300 C>T), RS1001016959 (22:35706761 G>A), RS1001260856 (22:35711169 C>T), RS1001281295 (22:35727393 A>C)

Disease associations

OMIM: gene MIM:607255 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST002301_5Body mass index3.000000e-06
GCST005958_13Waist-to-hip ratio adjusted for BMI (age >50)1.000000e-06
GCST005962_33Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)6.000000e-06

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0008007age at assessment
EFO:0008343sex interaction measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
3,4,5,3’,4’-pentachlorobiphenyldecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Benzo(a)pyreneincreases methylation1
Cadmiumdecreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Rotenoneincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.